Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Accentuate the Positive: Cramer's 'Mad Money' Recap (Monday 1/11/21)
By Scott Rutt
Jan 11, 2021 8:27 PM EST
PRESS RELEASES
Bluebird Bio To Separate Oncology Business Into Independent Company
By Business Wire
Jan 11, 2021 6:30 AM EST
PRESS RELEASES
Bristol Myers Squibb And Bluebird Bio Present Data Highlighting Anti-BCMA CAR T Cell Therapy, Ide-cel, In Relapsed And Refractory Multiple Myeloma At ASH 2020
By Business Wire
Dec 5, 2020 12:30 PM EST
PRESS RELEASES
Magenta Therapeutics And Bluebird Bio Announce A Phase 2 Clinical Trial Collaboration To Evaluate Magenta's MGTA-145 For Mobilizing And Collecting Stem Cells In Adults And Adolescents With Sickle Cell Disease
By Business Wire
Dec 4, 2020 8:00 AM EST
PRESS RELEASES
Bluebird Bio Announces Live Webcast To Review Clinical Data Presented At The American Society Of Hematology (ASH) Annual Meeting
By Business Wire
Nov 24, 2020 8:00 AM EST
PRESS RELEASES
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Bluebird Bio, Inc. - BLUE
By PR Newswire
Nov 10, 2020 9:29 PM EST
PRESS RELEASES
Bluebird Bio Announces November Investor Events
By Business Wire
Nov 10, 2020 8:00 AM EST
INVESTING
Bluebird Bio Off on Delay in Sickle-Cell Treatment Submission
By Rob Lenihan
Nov 5, 2020 12:07 PM EST
PRESS RELEASES
Bluebird Bio To Present Data From Gene And Cell Therapy Programs During The 62nd American Society Of Hematology (ASH) Annual Meeting And Exposition
By Business Wire
Nov 5, 2020 7:30 AM EST
PRESS RELEASES
Bluebird Bio Announces European Medicines Agency's Acceptance Of Marketing Authorization Application (MAA) For Elivaldogene Autotemcel (eli-cel, Lenti-D™) Gene Therapy For Cerebral Adrenoleukodystrophy (CALD)
By Business Wire
Oct 2, 2020 5:00 AM EDT
PRESS RELEASES
Bluebird Bio To Present At Jefferies Cell Therapy Virtual Summit
By Business Wire
Sep 28, 2020 8:00 AM EDT
PRESS RELEASES
Bluebird Bio's LentiGlobin™ For Sickle Cell Disease Gene Therapy (bb1111) Granted Priority Medicines (PRIME) Designation By European Medicines Agency
By Business Wire
Sep 23, 2020 5:00 AM EDT
PRESS RELEASES
U.S. Food And Drug Administration (FDA) Accepts For Priority Review Bristol Myers Squibb And Bluebird Bio Application For Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, Bb2121)
By Business Wire
Sep 22, 2020 6:59 AM EDT
PRESS RELEASES
Bluebird Bio Announces September Investor Events
By Business Wire
Sep 2, 2020 8:00 AM EDT
PRESS RELEASES
Bluebird Bio To Present New Data From Clinical Studies Of Elivaldogene Autotemcel (eli-cel, Lenti-D™) Gene Therapy For Cerebral Adrenoleukodystrophy (CALD) At The Virtual Edition Of The 46th EBMT Annual Meeting
By Business Wire
Aug 17, 2020 7:00 AM EDT
PRESS RELEASES
Bluebird Bio Appoints Denice Torres To Board Of Directors
By Business Wire
Aug 11, 2020 7:01 AM EDT
PRESS RELEASES
Bluebird Bio Announces August Investor Event
By Business Wire
Jul 31, 2020 8:00 AM EDT
PRESS RELEASES
Bristol Myers Squibb And Bluebird Bio Announce Submission Of Biologics License Application (BLA) To FDA For Idecabtagene Vicleucel (Ide-cel, Bb2121) For Adults With Relapsed And Refractory Multiple Myeloma
By Business Wire
Jul 29, 2020 4:16 PM EDT
PRESS RELEASES
C-Suite At The Open: Robert Cinits, President & CEO, Blue Thunder Mining Inc. Tells His Company's Story. Filmed In June, 2020
By PR Newswire
Jul 22, 2020 10:00 AM EDT
PRESS RELEASES
Bluebird Bio Announces That Its 2020 Annual Meeting Of Stockholders Will Be Held In Virtual Format
By Business Wire
Jun 3, 2020 4:05 PM EDT
PRESS RELEASES
Bluebird Bio Announces Live Webcast Of EHA Data Review And June Investor Events
By Business Wire
May 28, 2020 8:00 AM EDT
PRESS RELEASES
Blue Thunder Mining Inc. Virtually Opens The Market
By PR Newswire
May 25, 2020 11:00 AM EDT
PRESS RELEASES
Bluebird Bio Announces Pricing Of Public Offering Of Common Stock
By Business Wire
May 18, 2020 9:32 PM EDT
PRESS RELEASES
Bluebird Bio Announces Proposed Public Offering Of Common Stock
By Business Wire
May 18, 2020 7:00 AM EDT
INVESTING
Bristol-Myers to Resubmit Myeloma-Drug Bid to FDA - Here’s the Trade
By Richard Suttmeier
May 13, 2020 1:15 PM EDT
